Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index; 33 of the 133 sources its claims cite were checked for support.

Neuroendocrine Disruptions Following Head Injury

Open access
Wexler, Tamara L. · 2023 · Current Neurology and Neuroscience Reports

Abstract

Purpose of review This article reviews hypopituitarism after TBI, the importance of pituitary hormones, and related controversies, concluding with a suggested patient approach. Recent findings While earlier studies focused on increased pituitary deficiencies after moderate-severe TBI, recent studies have focused on deficiencies after mild TBI. There has been increasing focus on the role of growth hormone after injury; growth hormone is the most frequent reported deficiency at 1 year post-TBI, and an area with unresolved questions. While more research is needed to quantify the risk of deficiencies in special populations, and establish the natural history, increasing data indicate an increase in hypopituitarism after other acquired brain injuries; the potential role of pituitary hormone deficiencies after stroke and after COVID-19 infection is an area of active inquiry. Given the negative health effects of untreated hypopituitarism and the opportunity to intervene via hormone replacement, it is important to recognize the role of pituitary hormone deficiencies after TBI.

Overview

CoChat Summary

TL;DR

This review summarizes evidence that traumatic brain injury, including mild and repetitive sports injury, increases the risk of chronic anterior pituitary hormone deficiencies that may appear delayed and can improve with hormone replacement. It emphasizes recognition, symptom-based screening, and unresolved controversies—especially around growth hormone deficiency diagnosis and treatment.

Key findings

  • Chronic pituitary dysfunction is reported in 15–60% of adults after TBI and up to 42% of children/adolescents; using guideline-based definitions, anterior pituitary deficiencies approximate 25–30% by 1 year after TBI, versus <0.05% in one healthy adult population study.
  • Deficiencies can develop late: in 70 adults evaluated at 3 and 12 months, 8% had more deficiencies at 12 months; in 58 children/adolescents assessed at 3, 6, and 12 months, 5 had new deficiencies at 12 months not present earlier.
  • Mild TBI and repetitive sports injury confer risk: among retired NFL players, GHD was diagnosed in 41.2% (28/68) using standard cutoff and 19.1% (13/68) using BMI-adjusted thresholds; in 58 veterans evaluated in a pituitary clinic, GHD was 20.7% and adrenal insufficiency 22.4%.
  • Acute neuroendocrine abnormalities are common but often transient: acute adrenal insufficiency rates range 9.8–78%, central DI/AVP-D 14–26%, and SIADH 2.5–14%; acute adrenal insufficiency does not correlate with chronic adrenal insufficiency.

Methods

  • Narrative review of hypopituitarism after TBI, covering acute and chronic anterior pituitary deficiencies, posterior pituitary dysfunction, hormone replacement, controversies, and a suggested practical patient approach.
  • Synthesizes published studies and guidelines; no primary cohort, systematic search, or meta-analysis is described.
  • Includes tables summarizing hypothalamic-pituitary-end organ hormones, evaluation/replacement of anterior pituitary deficiencies, and guideline recommendations for post-TBI pituitary management.

Limitations

  • Author-stated: exact incidence remains uncertain because reported rates vary by study design, cohort features, and hormone evaluation methods; GHD in particular has wide variation in test methodology and diagnostic thresholds.
  • Author-stated: the mechanism by which TBI leads to pituitary deficiencies remains unknown; no clinically useful predictor has been identified, and acute pituitary dysfunction does not correlate with chronic deficiencies.
  • Evident from text: as a narrative review, it provides no new primary data or systematic quantitative synthesis, and some recommendations reflect the author’s own practice in addition to cited guidelines.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s11910-023-01263-5

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

18 Valid · 16 Not valid · 25 Not checked · 23 Own results and interpretations

41 more claims · 13 with their cited sources checked

Create a free account to see all 82 claims and to verify the 5 references still open.

See all claims — free account
  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 21
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 71 references

Cited by

See all 23

Metadata

Authors
Wexler, T. L.
Affiliations
NYU Langone Health (US)
Corresponding author
Wexler, Tamara L.
Venue
Current Neurology and Neuroscience Reports
Published
2023-05
Volume
23
Issue
5
Pages
213-224
ISSN
  • 1528-4042 (ISSN-L)
  • 1534-6293
OpenAlex
W4372346066
Cited by
23
References
71
Citations by year
2026: 7 · 2025: 7 · 2024: 8 · 2023: 1
FWCI
0.83
Type
journal article
Language
en
Open access
Licence
Locations
  • Current Neurology and Neuroscience Reports (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
Keywords
hypopituitarism, traumatic brain injury, mild traumatic brain injury, growth hormone deficiency, pituitary hormones, acquired brain injury, stroke, COVID-19 pandemic, hormone replacement therapy, neuroendocrine disruption
MeSH terms
COVID-19, Brain Injuries, Humans, Hypopituitarism, Growth Hormone, Human Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroendocrine Disruptions Following Head Injury. https://app.cochat.ai/papers/10.1007/s11910-023-01263-5
The paper
Wexler, T. L. (2023). Neuroendocrine Disruptions Following Head Injury. Current Neurology and Neuroscience Reports. https://doi.org/10.1007/s11910-023-01263-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.